Iontophoresis

Definition & Mechanism

Iontophoresis is a technique in which direct electrical current (DC) is used to transport ionically charged drug molecules across the skin and mucous membranes without needles. The principle relies on electrostatic repulsion: a charged drug ion placed under an electrode of the same polarity is driven away from that electrode and into the tissue.

Positively charged drugs → placed under the anode (+)
Negatively charged drugs → placed under the cathode (−)
Drug penetration depth: 0.2–1.5 cm, depending on the agent and local tissue characteristics
Drug delivery rate is proportional to applied current, enabling programmable delivery — especially important with miniaturized microprocessor-based systems

(Dermatology 2-Volume Set 5e; Pfenninger and Fowler's Procedures for Primary Care)

Physics of Drug Delivery

Three processes drive transdermal ion movement:

Electrophoresis — direct migration of charged ions under an electric field (primary mechanism)
Electroosmosis — bulk flow of water (and dissolved solutes) toward the cathode
Electroporation (at higher voltages) — structural rearrangement of stratum corneum lipids creating pores (a separate but related technique)

Clinical Applications

1. Musculoskeletal / Anti-inflammatory

The most common clinical use is delivery of anti-inflammatory and analgesic agents to superficial musculoskeletal structures:

Ion / Drug	Polarity	Indication	Dose
Dexamethasone	Negative (−)	Tendinitis, tenosynovitis, bursitis, arthritis	1–4 mA × 15–20 min
Methylprednisolone	Negative (−)	Postherpetic neuralgia	1–4 mA × 15–20 min
Acetic acid	Negative (−)	Calcified tendinitis, calcium deposits	3–4 mA × 10–20 min
Salicylate	Negative (−)	Analgesia, myalgia, plantar warts	4 mA × 45 min
Iodine	Negative (−)	Fibrosis, scar tissue, trigger finger	2 mA × 1 min → 4 mA × 5 min
Chloride/sodium	Negative (−)	Keloids, scar tissue	4 mA × 20–45 min
Lidocaine 4%	Positive (+)	Skin anesthesia	4 mA × 20–30 min
Hyaluronidase	Positive (+)	Edema, lymphedema, scleroderma	1–2 mA × 20–40 min
Copper sulfate	Positive (+)	Fungal infection	4 mA × 20–30 min
Zinc	Positive (+)	Wound healing, ulcers	4 mA × 15 min

(Pfenninger and Fowler's Procedures for Primary Care)

2. Topical Anesthesia

Lidocaine with epinephrine delivered via iontophoresis provides adequate cutaneous anesthesia before venipuncture — particularly in pediatric patients — and is superior to EMLA for this purpose. Used before dermatologic procedures and IV insertion. (Roberts and Hedges' Clinical Procedures in Emergency Medicine)

3. Hyperhidrosis

In palmoplantar hyperhidrosis, tap or deionized water iontophoresis is an established treatment. The affected area is submerged in water; DC passes through at 8–20 mA for 10–20 minutes, 3–4 times weekly. The mechanism is incompletely understood but hypotheses include:

Obstruction of eccrine ducts at the stratum corneum level
Inhibition of sympathetic nerve transmission
Local pH alterations affecting sweat gland function

Adding glycopyrrolate to the water trays enhances efficacy. Home devices (e.g., Drionic®) are available. Works best on palms and soles; less effective for axillary hyperhidrosis.

(Fitzpatrick's Dermatology; Dermatology 2-Volume Set 5e)

4. Sweat Chloride Testing (Cystic Fibrosis Diagnosis)

Iontophoresis of pilocarpine nitrate is the first step of the quantitative pilocarpine iontophoresis sweat test (Gibson-Cooke method). Pilocarpine stimulates localized sweat gland secretion; the collected sweat is analyzed for chloride concentration — the gold standard for CF diagnosis. (Tietz Textbook of Laboratory Medicine)

5. Other Applications (Emerging/Investigational)

Fentanyl — patient-controlled transdermal pain relief
Sumatriptan — migraine relief
Reverse iontophoresis — extraction of glucose from skin for non-invasive glucose monitoring in diabetic patients
Chemotherapeutic delivery into superficial skin tumors (combined with electroporation)

Equipment & Technique

Equipment needed:

DC generator with constant current output (calibrated in mA)
Active electrode (drug reservoir) and dispersive/return electrode
Appropriate medication

Technique (summary):

Inspect skin; clip (do not shave) hair; clean with 70% isopropyl alcohol
Fill active electrode reservoir with medication per manufacturer specs
Apply active electrode over treatment area, dispersive electrode at a remote site
Set current 0.1–4 mA; gradually increase to patient tolerance (tingling sensation)
Treat for 10–20 minutes; monitor every 2–4 minutes
Electrical dose = intensity (mA) × duration (min) = mA·min

Wearable battery-powered patches are also available, delivering 0.06–0.45 mA continuously over 3–24 hours with auto-shutoff. (Pfenninger and Fowler's)

Iontophoresis current generator with agent, syringe, alcohol wipe, electrodes, and leads

Iontophoresis current generator with iontophoresis agent, measuring syringe, alcohol wipe for skin preparation, electrodes, and electrode leads.

Iontophoresis treatment patch applied to arm connected to a handheld device

Iontophoresis treatment in progress.

Contraindications

Category	Specific Contraindication
Systemic	Pacemakers or implanted cardiac devices
Drug-related	Known allergy/sensitivity to the therapeutic agent
Skin / Local	Superficial abrasions, cuts, bruises; recent bleeding; recent scars or skin grafts
Anatomical	Over the heart; over the carotid sinus; over metallic implants (screws, staples, wires)
Sensory	Areas of abnormal or absent sensation (patient must provide feedback to set current correctly)

Complications

Complication	Description
Galvanic rash	Hypersensitivity to DC; appears within 5 min of initiating stimulation
Electrode (cathode) burn	Alkaline reaction under the negative electrode; decreased skin resistance allows excess current; newer buffered electrodes reduce this
Twitch response	Inadvertent nerve stimulation from inappropriate current level
Post-treatment erythema	Common; from skin pH changes or local histamine release
Drug allergy	Previously unknown sensitivity to the iontophoresed agent
Irritation / blisters	Particularly with hyperhidrosis treatment at higher currents
Burns	Rare; risk with pilocarpine iontophoresis sweat testing

Key Points

Works best when the pathologic process is superficial and localized
Dexamethasone is the primary agent for inflammation; lidocaine for topical anesthesia
The drug must be ionizable in solution and placed under the electrode of the same charge
Maximum penetration is ~1.5 cm — a practical limit for selecting appropriate indications
Iontophoresis is CPT-coded (97033, each 15-minute application) and reimbursable in primary care settings

This is a shared conversation. Sign in to Orris to start your own chat.